Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 339

1.

Title: Dietary Sodium Intake is Associated with Long-Term Risk of New-Onset Atrial Fibrillation.

Pääkkö TJW, Perkiömäki JS, Silaste ML, Bloigu R, Huikuri HV, Kesäniemi YA, Ukkola OH.

Ann Med. 2018 Nov 15:1-27. doi: 10.1080/07853890.2018.1546054. [Epub ahead of print]

PMID:
30442022
2.

Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study).

Kattelus H, Kesäniemi YA, Huikuri H, Ukkola O.

PLoS One. 2018 Oct 5;13(10):e0205454. doi: 10.1371/journal.pone.0205454. eCollection 2018.

3.

Effect of simvastatin and ezetimibe on suPAR levels and outcomes.

Hodges GW, Bang CN, Forman JL, Olsen MH, Boman K, Ray S, Kesäniemi YA, Eugen-Olsen J, Greve AM, Jeppesen JL, Wachtell K.

Atherosclerosis. 2018 May;272:129-136. doi: 10.1016/j.atherosclerosis.2018.03.030. Epub 2018 Mar 16.

PMID:
29602140
4.

Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study.

Waldman B, Ansquer JC, Sullivan DR, Jenkins AJ, McGill N, Buizen L, Davis TME, Best JD, Li L, Feher MD, Foucher C, Kesaniemi YA, Flack J, d'Emden MC, Scott RS, Hedley J, Gebski V, Keech AC; FIELD investigators.

Lancet Diabetes Endocrinol. 2018 Apr;6(4):310-318. doi: 10.1016/S2213-8587(18)30029-9. Epub 2018 Feb 26.

PMID:
29496472
5.

Increasing ambulatory pulse pressure predicts the development of left ventricular hypertrophy during long-term follow-up.

Pääkkö TJW, Perkiömäki JS, Kesäniemi YA, Ylitalo AS, Lumme JA, Huikuri HV, Ukkola OH.

J Hum Hypertens. 2018 Mar;32(3):180-189. doi: 10.1038/s41371-018-0034-5. Epub 2018 Feb 7.

PMID:
29416118
6.

Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study).

Greve AM, Bang CN, Boman K, Egstrup K, Forman JL, Kesäniemi YA, Ray S, Pedersen TR, Best P, Rajamannan NM, Wachtell K.

Am J Cardiol. 2018 Mar 15;121(6):739-745. doi: 10.1016/j.amjcard.2017.12.011. Epub 2017 Dec 25.

PMID:
29361285
7.

IgA antibodies to phosphocholine associate with long-term cardiovascular disease risk.

Kankaanpää J, Sämpi M, Bloigu R, Wang C, Akhi R, Kesäniemi YA, Remes AM, Ukkola O, Hörkkö S.

Atherosclerosis. 2018 Feb;269:294-300. doi: 10.1016/j.atherosclerosis.2017.12.010. Epub 2017 Dec 8.

PMID:
29277441
8.

Case fatality of acute coronary events is improving even among elderly patients; the FINAMI study 1995-2012.

Koukkunen H, Havulinna AS, Lehto S, Ketonen M, Mustonen J, Airaksinen JK, Ukkola O, Kesäniemi YA, Salomaa V; FINAMI Study Group.

Ann Med. 2018 Feb;50(1):35-45. doi: 10.1080/07853890.2017.1382713. Epub 2017 Oct 3.

PMID:
28927303
9.

Ambulatory Pulse Pressure Predicts the Development of Left Ventricular Diastolic Dysfunction in Over 20 Years of Follow-up.

Pääkkö TJW, Renko RJ, Perkiömäki JS, Kesäniemi YA, Ylitalo AS, Lumme JA, Huikuri HV, Ruskoaho H, Vuolteenaho O, Ukkola OH.

Am J Hypertens. 2017 Oct 1;30(10):985-992. doi: 10.1093/ajh/hpx087.

PMID:
28911024
10.

Cardiac Remodeling from Middle Age to Senescence.

Möttönen MJ, Ukkola O, Lumme J, Kesäniemi YA, Huikuri HV, Perkiömäki JS.

Front Physiol. 2017 May 26;8:341. doi: 10.3389/fphys.2017.00341. eCollection 2017.

11.

A Low-Frequency Inactivating AKT2 Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk.

Manning A, Highland HM, Gasser J, Sim X, Tukiainen T, Fontanillas P, Grarup N, Rivas MA, Mahajan A, Locke AE, Cingolani P, Pers TH, Viñuela A, Brown AA, Wu Y, Flannick J, Fuchsberger C, Gamazon ER, Gaulton KJ, Im HK, Teslovich TM, Blackwell TW, Bork-Jensen J, Burtt NP, Chen Y, Green T, Hartl C, Kang HM, Kumar A, Ladenvall C, Ma C, Moutsianas L, Pearson RD, Perry JRB, Rayner NW, Robertson NR, Scott LJ, van de Bunt M, Eriksson JG, Jula A, Koskinen S, Lehtimäki T, Palotie A, Raitakari OT, Jacobs SBR, Wessel J, Chu AY, Scott RA, Goodarzi MO, Blancher C, Buck G, Buck D, Chines PS, Gabriel S, Gjesing AP, Groves CJ, Hollensted M, Huyghe JR, Jackson AU, Jun G, Justesen JM, Mangino M, Murphy J, Neville M, Onofrio R, Small KS, Stringham HM, Trakalo J, Banks E, Carey J, Carneiro MO, DePristo M, Farjoun Y, Fennell T, Goldstein JI, Grant G, Hrabé de Angelis M, Maguire J, Neale BM, Poplin R, Purcell S, Schwarzmayr T, Shakir K, Smith JD, Strom TM, Wieland T, Lindstrom J, Brandslund I, Christensen C, Surdulescu GL, Lakka TA, Doney ASF, Nilsson P, Wareham NJ, Langenberg C, Varga TV, Franks PW, Rolandsson O, Rosengren AH, Farook VS, Thameem F, Puppala S, Kumar S, Lehman DM, Jenkinson CP, Curran JE, Hale DE, Fowler SP, Arya R, DeFronzo RA, Abboud HE, Syvänen AC, Hicks PJ, Palmer ND, Ng MCY, Bowden DW, Freedman BI, Esko T, Mägi R, Milani L, Mihailov E, Metspalu A, Narisu N, Kinnunen L, Bonnycastle LL, Swift A, Pasko D, Wood AR, Fadista J, Pollin TI, Barzilai N, Atzmon G, Glaser B, Thorand B, Strauch K, Peters A, Roden M, Müller-Nurasyid M, Liang L, Kriebel J, Illig T, Grallert H, Gieger C, Meisinger C, Lannfelt L, Musani SK, Griswold M, Taylor HA Jr, Wilson G Sr, Correa A, Oksa H, Scott WR, Afzal U, Tan ST, Loh M, Chambers JC, Sehmi J, Kooner JS, Lehne B, Cho YS, Lee JY, Han BG, Käräjämäki A, Qi Q, Qi L, Huang J, Hu FB, Melander O, Orho-Melander M, Below JE, Aguilar D, Wong TY, Liu J, Khor CC, Chia KS, Lim WY, Cheng CY, Chan E, Tai ES, Aung T, Linneberg A, Isomaa B, Meitinger T, Tuomi T, Hakaste L, Kravic J, Jørgensen ME, Lauritzen T, Deloukas P, Stirrups KE, Owen KR, Farmer AJ, Frayling TM, O'Rahilly SP, Walker M, Levy JC, Hodgkiss D, Hattersley AT, Kuulasmaa T, Stančáková A, Barroso I, Bharadwaj D, Chan J, Chandak GR, Daly MJ, Donnelly PJ, Ebrahim SB, Elliott P, Fingerlin T, Froguel P, Hu C, Jia W, Ma RCW, McVean G, Park T, Prabhakaran D, Sandhu M, Scott J, Sladek R, Tandon N, Teo YY, Zeggini E, Watanabe RM, Koistinen HA, Kesaniemi YA, Uusitupa M, Spector TD, Salomaa V, Rauramaa R, Palmer CNA, Prokopenko I, Morris AD, Bergman RN, Collins FS, Lind L, Ingelsson E, Tuomilehto J, Karpe F, Groop L, Jørgensen T, Hansen T, Pedersen O, Kuusisto J, Abecasis G, Bell GI, Blangero J, Cox NJ, Duggirala R, Seielstad M, Wilson JG, Dupuis J, Ripatti S, Hanis CL, Florez JC, Mohlke KL, Meigs JB, Laakso M, Morris AP, Boehnke M, Altshuler D, McCarthy MI, Gloyn AL, Lindgren CM.

Diabetes. 2017 Jul;66(7):2019-2032. doi: 10.2337/db16-1329. Epub 2017 Mar 24.

12.

Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.

Käräjämäki AJ, Kettunen O, Lepojärvi S, Koivurova OP, Kesäniemi YA, Huikuri H, Ukkola O.

PLoS One. 2017 Mar 13;12(3):e0173855. doi: 10.1371/journal.pone.0173855. eCollection 2017.

13.

Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention.

Bohula EA, Morrow DA, Giugliano RP, Blazing MA, He P, Park JG, Murphy SA, White JA, Kesaniemi YA, Pedersen TR, Brady AJ, Mitchel Y, Cannon CP, Braunwald E.

J Am Coll Cardiol. 2017 Feb 28;69(8):911-921. doi: 10.1016/j.jacc.2016.11.070.

14.

Decreased mortality risk due to first acute coronary syndrome in women with postmenopausal hormone therapy use.

Tuomikoski P, Salomaa V, Havulinna A, Airaksinen J, Ketonen M, Koukkunen H, Ukkola O, Kesäniemi YA, Lyytinen H, Ylikorkala O, Mikkola TS.

Maturitas. 2016 Dec;94:106-109. doi: 10.1016/j.maturitas.2016.09.015. Epub 2016 Sep 28.

PMID:
27823727
15.

SuPAR Predicts Cardiovascular Events and Mortality in Patients With Asymptomatic Aortic Stenosis.

Hodges GW, Bang CN, Eugen-Olsen J, Olsen MH, Boman K, Ray S, Gohlke-Bärwolf C, Kesäniemi YA, Jeppesen JL, Wachtell K.

Can J Cardiol. 2016 Dec;32(12):1462-1469. doi: 10.1016/j.cjca.2016.04.012. Epub 2016 May 3.

PMID:
27499378
16.

Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS).

Nielsen OW, Sajadieh A, Sabbah M, Greve AM, Olsen MH, Boman K, Nienaber CA, Kesäniemi YA, Pedersen TR, Willenheimer R, Wachtell K.

Circulation. 2016 Aug 9;134(6):455-68. doi: 10.1161/CIRCULATIONAHA.115.021213. Epub 2016 Aug 2.

PMID:
27486164
17.

Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes.

Käräjämäki AJ, Bloigu R, Kauma H, Kesäniemi YA, Koivurova OP, Perkiömäki J, Huikuri H, Ukkola O.

Metabolism. 2017 Jan;66:55-63. doi: 10.1016/j.metabol.2016.06.009. Epub 2016 Jul 1.

PMID:
27423871
18.

Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).

Käräjämäki AJ, Pätsi OP, Savolainen M, Kesäniemi YA, Huikuri H, Ukkola O.

PLoS One. 2015 Nov 16;10(11):e0142937. doi: 10.1371/journal.pone.0142937. eCollection 2015.

19.

The fat mass and obesity-associated (FTO) gene variant rs9939609 predicts long-term incidence of cardiovascular disease and related death independent of the traditional risk factors.

Äijälä M, Ronkainen J, Huusko T, Malo E, Savolainen ER, Savolainen MJ, Salonurmi T, Bloigu R, Kesäniemi YA, Ukkola O.

Ann Med. 2015;47(8):655-63. doi: 10.3109/07853890.2015.1091088. Epub 2015 Nov 11.

PMID:
26555680
20.

Predictors of Development of Echocardiographic Left Ventricular Diastolic Dysfunction in the Subjects Aged 40 to 59 Years (from the Oulu Project Elucidating Risk of Atherosclerosis Study).

Perkiömäki JS, Möttönen M, Lumme J, Kesäniemi YA, Ukkola O, Huikuri HV.

Am J Cardiol. 2015 Nov 1;116(9):1374-8. doi: 10.1016/j.amjcard.2015.07.054. Epub 2015 Aug 14.

PMID:
26341186

Supplemental Content

Loading ...
Support Center